Throughout the last three months, 16 analysts have evaluated Colgate-Palmolive (NYSE:CL), offering a diverse set of opinions from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Colgate-Palmolive, presenting an average target of $106.81, a high estimate of $122.00, and a low estimate of $91.00. This upward trend is apparent, with the current average reflecting a 4.56% increase from the previous average price target of $102.15.

Investigating Analyst Ratings: An Elaborate Study

In...